Chargement en cours...

Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial-to-mesenchymal transition in colon and breast cancers

The Nef-M1 peptide competes effectively with the natural ligand of CXC chemokine receptor 4 (CXCR4), stromal cell-derived factor 1-alpha, to induce apoptosis and inhibit growth in colon cancer (CRC) and breast cancer (BC). Its role in tumor angiogenesis, and epithelial-to-mesenchymal transition (EMT...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Katkoori, Venkat R., Basson, Marc D., Bond, Vincent C., Manne, Upender, Bumpers, Harvey L.
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4695024/
https://ncbi.nlm.nih.gov/pubmed/26318034
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!